Mesoblast

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.

CEO

Silviu Itescu

CEOSilviu Itescu

Employees

Employees83

Headquarters

Melbourne, Victoria (VIC)

HeadquartersMelbourne, Victoria (VIC)

Founded

2004

Founded2004

Employees

Employees83

MESO Key Statistics

Market cap

862.78M

Market cap862.78M

Price-Earnings ratio

-7.14

Price-Earnings ratio-7.14

Dividend yield

—

Dividend yield—

Average volume

337.28K

Average volume337.28K

High today

$7.75

High today$7.75

Low today

$7.24

Low today$7.24

Open price

$7.64

Open price$7.64

Volume

344.15K

Volume344.15K

52 Week high

$10.24

52 Week high$10.24

52 Week low

$1.61

52 Week low$1.61

MESO News

TipRanks 6d

Mesoblast Director Boosts Stake, Awaits Shares Approval - TipRanks.com - TipRanks

Mesoblast (MESO) has released an update. Mesoblast Limited has announced that their Director, Dr. Eric Rose, acquired 21,428 American Depositary Shares (ADS) o...